头颈癌患者颧骨种植体一期与二期植入的前瞻性10年研究
该前瞻性研究纳入2006至2016年间接受颧骨种植体植入作为肿瘤治疗一部分的49例连续患者,共植入131枚颧骨种植体,其中9枚失败并从4例患者中取出;24例(49%)在植入前后接受放疗。12个月总生存估计为94%,60个月为92%。结论认为颧骨种植体是上颌及面中部恶性肿瘤修复重建的可预测方式,种植体存留率高,与是否行游离组织移植、植入时机或辅助放疗需求无关。
要点
- 49例头颈癌患者共植入131枚颧骨种植体,9枚失败取出,涉及4例患者。
- 24例(49%)在种植体植入前后接受放疗。
- 12个月总生存估计94%,60个月估计92%。
核心结论
- 颧骨种植体用于上颌及面中部恶性肿瘤管理是可预测的修复治疗方式,可支持复杂的口内及面部假体。
- 无论是否联合游离组织移植,颧骨种植体均可提供有效的修复重建,种植体存留率高,与植入时机或辅助放疗需求无关。
研究设计与样本
- 前瞻性研究,纳入2006年至2016年间由作者植入颧骨种植体作为肿瘤治疗一部分的患者,连续治疗49例,共植入131枚颧骨种植体。
主要发现
- 49例连续治疗患者共植入131枚颧骨种植体,其中9枚失败并从4例患者中取出。
- 24例患者(49%)在种植体植入前或后接受放疗。
- 12个月总生存估计为94%,60个月估计为92%。
临床怎么用
- 颧骨种植体为受上颌及面中部恶性肿瘤影响的牙列和面部结构修复提供了良好平台。
- 颧骨种植体可联合或不联合游离组织移植使用,以提供有效的修复重建,种植体存留率高,与植入时机或辅助放疗需求无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Zygomatic implants can provide excellent remote anchorage to support the prosthetic rehabilitation of patients treated for maxillary and midfacial tumors. METHODS: Patients who underwent zygomatic implant placement by the author between 2006 and 2016 as part of their oncology treatment were followed prospectively. RESULTS: Forty-nine consecutively treated patients received 131 zygomatic implants of which 9 failed and were removed from 4 patients; 24 patients (49%) received radiotherapy either before or after implant insertion. The overall 12-month survival estimate was 94% and the 60-month estimate was 92%. CONCLUSIONS: The use of zygomatic implants in the management of maxillary and midfacial malignancy is a predictable prosthetic treatment modality to support complex oral and facial prostheses. Their use with or without free tissue transfer can provide effective prosthetic rehabilitation with high implant survival irrespective of the timing of placement or the need for adjuvant radiotherapy. CLINICAL SIGNIFICANCE: Zygomatic Implants provide an excellent platform for the restoration of the dentition and facial structures affected by maxillary and midfacial malignant disease.
引用
- Butterworth CJ. Primary vs secondary zygomatic implant placement in patients with head and neck cancer-A 10-year prospective study. Head Neck. 2019. PMID: 30664292. doi:10.1002/hed.25645
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。